Journal of Cancer Survivorship

, Volume 5, Issue 1, pp 8–17 | Cite as

Complementary and alternative medicine use among cancer survivors: a population-based study

  • Jun James MaoEmail author
  • Christina Shearer PalmerEmail author
  • Kaitlin Elizabeth Healy
  • Krupali Desai
  • Jay Amsterdam



The use of complementary and alternative medicine (CAM) among cancer survivors is high, yet less is known about reasons behind such use or the communication of CAM with conventional medical providers.


Cross-sectional, multivariate logistic regression models were developed to evaluate the similarities and differences between cancer survivors and non-cancer controls in the 2007 National Health Interview Survey with 23,393 participants, including 1,471 cancer survivors.


Among cancer survivors, 66.5% reported ever using CAM and 43.3% having used CAM in the past year. When compared with the general population, cancer survivors used CAM more often for general disease prevention, immune enhancement, and for pain (Adjusted Odds Ratio [AOR] 1.27, 95% Confidence Interval [CI] 1.10–1.48; AOR 1.32, 95% CI 1.05–1.62; AOR 1.42, 95% CI 1.05–1.92, respectively). Cancer survivors were more likely to use CAM because of recommendations from their provider (AOR 1.54, 95% CI 1.26–1.88) and were more likely to disclose their CAM use to their provider (AOR 1.45, 95% CI 1.22–1.72).


When compared to the general population, cancer survivors were more likely to use CAM and communicate this use with providers, indicating a growing integration of CAM in conventional medical care.

Implications for Cancer Survivors

Cancer survivors are more likely than the general population to communicate CAM use with providers, suggesting greater integration of CAM use in conventional care. However, the majority of CAM use is still not being communicated to providers, indicating an important area for improvement in patient-centered care.


Complementary therapies Clinical oncology Communication 


Disclosure of interests

Dr. Mao is supported by a K23 AT004112 grant from National Institutes of Health and a CCCDA-08-107 grant from the American Cancer Society. The funding agencies had no role in the design and conduct of the study.


  1. 1.
    Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (eds). SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD,, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
  2. 2.
    Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998;83(4):777–82.CrossRefPubMedGoogle Scholar
  3. 3.
    Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.PubMedGoogle Scholar
  4. 4.
    Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol. 2005;23(12):2590–2.CrossRefPubMedGoogle Scholar
  5. 5.
    Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:4.CrossRefPubMedGoogle Scholar
  6. 6.
    Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15(1):21–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER. The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psychooncology. 2008;17(1):19–25.CrossRefPubMedGoogle Scholar
  8. 8.
    Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007;20(5):434–43.CrossRefPubMedGoogle Scholar
  9. 9.
    Rowland JH, Baker F. Introduction: resilience of cancer survivors across the lifespan. Cancer. 2005;104(11 Suppl):2543–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Supplement):2565–76.CrossRefPubMedGoogle Scholar
  11. 11.
    Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. Jama. 1998;280(18):1569–75.CrossRefPubMedGoogle Scholar
  12. 12.
    Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;27(343):1–19.Google Scholar
  13. 13.
    Henderson JW, Donatelle RJ. The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-oncology. 2003;12(1):59–67.CrossRefPubMedGoogle Scholar
  14. 14.
    Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther. 2005;4(2):187–94.CrossRefPubMedGoogle Scholar
  15. 15.
    Astin JA, Reilly C, Perkins C, Child WL. Breast cancer patients’ perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. J Soc Integr Oncol. 2006;4(4):157–69.CrossRefPubMedGoogle Scholar
  16. 16.
    Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med. 2002;2:8.CrossRefPubMedGoogle Scholar
  17. 17.
    Humpel N, Jones SC. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care Engl. 2006;15(4):362–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol. 1998;51(12):1285–92.CrossRefPubMedGoogle Scholar
  19. 19.
    Barg FK, Cronholm PF, Straton JB, Keddem S, Knott K, Grater J, et al. Unmet psychosocial needs of Pennsylvanians with cancer: 1986–2005. Cancer. 2007;110(3):631–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Mao JJ, Palmer SC, Straton J, Cronholm P, Keddem S, Knott K, et al. Cancer survivors with unmet needs were more likely to use complementary and alternative medicine. J Cancer Surviv. 2008. doi: 101007/s11764-008-0052-3.PubMedGoogle Scholar
  21. 21.
    Ashikaga T, Bosompra K, O’Brien P, Nelson L. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10(7):542–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology. 2002;11(3):212–20.CrossRefPubMedGoogle Scholar
  23. 23.
    Monti DA, Yang J. Complementary medicine in chronic cancer care. Semin Oncol. 2005;32(2):225–31.CrossRefPubMedGoogle Scholar
  24. 24.
    Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin. 2005;55(2):109–16.CrossRefPubMedGoogle Scholar
  25. 25.
    Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340(22):1733–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Yap KP, McCready DR, Fyles A, Manchul L, Trudeau M, Narod S. Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery. Breast J. 2004;10(6):481–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137(11):889–903.PubMedGoogle Scholar
  28. 28.
    Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, et al. Heavy metal content of ayurvedic herbal medicine products. Jama. 2004;292(23):2868–73.CrossRefPubMedGoogle Scholar
  29. 29.
    Matthews SC, Camacho A, Mills PJ, Dimsdale JE. The internet for medical information about cancer: help or hindrance? Psychosomatics. 2003;44(2):100–3.CrossRefPubMedGoogle Scholar
  30. 30.
    Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Ann Oncol. 2004;15(5):733–42.CrossRefPubMedGoogle Scholar
  31. 31.
  32. 32.
    Yabroff K, Lawrence W, Clauser S, Davis W, Brown M. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.CrossRefPubMedGoogle Scholar
  33. 33.
    (NHIS) NCfHSNHIS. Available from: 2007 data release.
  34. 34.
  35. 35.
    (NCCAM) NCfCaAM. Expanding horizons of health care: Strategic plan 2005–2009. Available from:
  36. 36.
    Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;10(12):1–23.Google Scholar
  37. 37.
    American Statistical Association. Section on survey research methods: summary of survey analysis software. 2005.Google Scholar
  38. 38.
    Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;30(18):1–14.Google Scholar
  39. 39.
    Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–30.CrossRefPubMedGoogle Scholar
  40. 40.
    Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana; 2008.Google Scholar
  41. 41.
    Brauer JA, El Sehamy A, Metz JM, Mao JJ. Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of websites. J Altern Complement Med. 2010;16(2):183-6.CrossRefPubMedGoogle Scholar
  42. 42.
    Cassileth BR. Society for integrative oncology first international conference, New York City, November 2004. Welcome address. J Soc Integr Oncol. 2005;3(4):121.CrossRefPubMedGoogle Scholar
  43. 43.
    Gardiner P, Kemper KJ, Legedza A, Phillips RS. Factors associated with herb and dietary supplement use by young adults in the United States. BMC Complement Altern Med. 2007;7:39.CrossRefPubMedGoogle Scholar
  44. 44.
    Richardson MA, Masse LC, Nanny K, Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer. 2004;12(11):797–804.CrossRefPubMedGoogle Scholar
  45. 45.
    Sleath B, Callahan L, DeVellis RF, Sloane PD. Patients’ perceptions of primary care physicians’ participatory decision-making style and communication about complementary and alternative medicine for arthritis. J Altern Complement Med. 2005;11(3):449–53.CrossRefPubMedGoogle Scholar
  46. 46.
    Swenson SL, Buell S, Zettler P, White M, Ruston DC, Lo B. Patient-centered communication: do patients really prefer it? J Gen Intern Med. 2004;19(11):1069–79.CrossRefPubMedGoogle Scholar
  47. 47.
    Roberts C, Benjamin H, Chen L, Gavigan M, Gesme DH, McCarthy P, et al. Assessing communication between oncology professionals and their patients. J Cancer Educ. 2005;20(2):113–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, et al. Race, gender, and partnership in the patient-physician relationship. Jama. 1999;282(6):583–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153(3):299–306.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Jun James Mao
    • 1
    • 2
    Email author
  • Christina Shearer Palmer
    • 1
    Email author
  • Kaitlin Elizabeth Healy
    • 1
  • Krupali Desai
    • 1
  • Jay Amsterdam
    • 3
  1. 1.Department of Family Medicine and Community HealthUniversity of Pennsylvania School of MedicinePhiladelphiaUSA
  2. 2.Abramson Cancer CenterUniversity of Pennsylvania School of MedicinePhiladelphiaUSA
  3. 3.Department of PsychiatryUniversity of Pennsylvania School of MedicinePhiladelphiaUSA

Personalised recommendations